Annenberg Center for Health Sciences
Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM
Erfahren Sie mehr über neue Behandlungsmöglichkeiten für Myasthenia gravis und wie Experten die Lebensqualität der Patienten verbessern und Therapielimitierungen überwinden.
Wrap Up
2 mins • Nov 19, 2024
Charts
This show is not currently ranked in any charts.
Neueste Folgen
Nov 19, 2024
Wrap Up
2 mins
Nov 19, 2024
Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT
3 mins
Nov 19, 2024
Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study
3 mins
Nov 19, 2024
Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results
3 mins
Nov 19, 2024
Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT
3 mins
Sprache
Englisch
Land
Vereinigte Staaten
Feed Host
Website
Feed
Aktualisierung anfordern
Aktualisierungen können einige Minuten dauern.